479 related articles for article (PubMed ID: 29334905)
21. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.
Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH
Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
24. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
Tselikas L; Pigneur F; Roux M; Baranes L; Costentin C; Roche V; Calderaro J; Herin E; Laurent A; Zafrani E; Azoulay D; Mallat A; Rahmouni A; Luciani A
Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
[TBL] [Abstract][Full Text] [Related]
25. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
[TBL] [Abstract][Full Text] [Related]
26. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
27. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
Nougaret S; Monsonis B; Molinari N; Riviere B; Piron L; Kassam Z; Cassinotto C; Guiu B
Eur Radiol; 2020 Sep; 30(9):4752-4761. PubMed ID: 32318848
[TBL] [Abstract][Full Text] [Related]
28. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
29. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
van den Esschert JW; van Gulik TM; Phoa SS
Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
31. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.
Yen YH; Wang JH; Lu SN; Chen TY; Changchien CS; Chen CH; Hung CH; Lee CM
Eur J Radiol; 2006 Dec; 60(3):439-44. PubMed ID: 16916591
[TBL] [Abstract][Full Text] [Related]
32. Is hepatotropic contrast enhanced MR a more effective method in differential diagnosis of hemangioma than multi-phase CT and unenhanced MR?
Szurowska E; Nowicki T; Izycka-Swieszewska E; Wypych J; Drobinska-Jurowiecka A; Markiet K; Szarmach A; Studniarek M
BMC Gastroenterol; 2011 Apr; 11():43. PubMed ID: 21504593
[TBL] [Abstract][Full Text] [Related]
33. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
Suh CH; Kim KW; Park SH; Shin S; Ahn J; Pyo J; Shinagare AB; Krajewski KM; Ramaiya NH
Eur Radiol; 2018 Jan; 28(1):214-225. PubMed ID: 28726119
[TBL] [Abstract][Full Text] [Related]
34. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
35. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
36. To assess the quantitative features of focal liver lesions in gadoxetic acid enhanced MRI and to determine whether these features can accurately differentiate benign form malignant lesions.
Rybczynska DN; Markiet KE; Pienkowska JM; Szurowska E; Frydrychowski A
Eur J Radiol; 2024 Feb; 171():111288. PubMed ID: 38194844
[TBL] [Abstract][Full Text] [Related]
37. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A
Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
